Search research articles
Contact Us
Filters
Showing results (1-10 of 283) with videos related to
Page
of 29
Sort By:
PET Clinics
|
May 10, 2016
Preface
Robert H Mach
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 19, 2014
New targets for the development of PET tracers for imaging neurodegeneration in Alzheimer disease
Robert H Mach
Seminars in Nuclear Medicine
|
August 23, 2017
Small Molecule Receptor Ligands for PET Studies of the Central Nervous System-Focus on G Protein Coupled Receptors
Robert H Mach
Progress in Molecular Biology and Translational Science
|
September 5, 2019
Development of brain PET imaging agents: Strategies for imaging neuroinflammation in Alzheimer's disease
Bieneke Janssen, Robert H Mach
Advances in Experimental Medicine and Biology
|
March 19, 2017
The Evolution of the Sigma-2 (σ<sub>2</sub>) Receptor from Obscure Binding Site to Bona Fide Therapeutic Target
Chenbo Zeng, Robert H Mach
Current Pharmaceutical Design
|
February 7, 2003
Progress in developing D3 dopamine receptor ligands as potential therapeutic agents for neurological and neuropsychiatric disorders
Robert R Luedtkea, Robert H Mach
Journal of Labelled Compounds & Radiopharmaceuticals
|
September 1, 2017
Challenges in the development of dopamine D2- and D3-selective radiotracers for PET imaging studies
Robert H Mach, Robert R Luedtke
PET Clinics
|
May 10, 2016
Challenges for Developing PET Tracers: Isotopes, Chemistry, and Regulatory Aspects
Robert H Mach, Sally W Schwarz
Organic Letters
|
October 14, 2016
Pd-Catalyzed Synthesis of Piperazine Scaffolds Under Aerobic and Solvent-Free Conditions
Sean W Reilly, Robert H Mach
Molecular Imaging and Biology
|
September 4, 2015
The PGRMC1 Protein Level Correlates with the Binding Activity of a Sigma-2 Fluorescent Probe (SW120) in Rat Brain Cells
Chenbo Zeng, Neha Garg, Robert H Mach
Page
of 29
Search research articles
Search
Showing results (1-10 of 283) with videos related to
Sort By:
Page
of 29
PET Clinics
|
May 10, 2016
Preface
Robert H Mach
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 19, 2014
New targets for the development of PET tracers for imaging neurodegeneration in Alzheimer disease
Robert H Mach
Seminars in Nuclear Medicine
|
August 23, 2017
Small Molecule Receptor Ligands for PET Studies of the Central Nervous System-Focus on G Protein Coupled Receptors
Robert H Mach
Progress in Molecular Biology and Translational Science
|
September 5, 2019
Development of brain PET imaging agents: Strategies for imaging neuroinflammation in Alzheimer's disease
Bieneke Janssen, Robert H Mach
Advances in Experimental Medicine and Biology
|
March 19, 2017
The Evolution of the Sigma-2 (σ<sub>2</sub>) Receptor from Obscure Binding Site to Bona Fide Therapeutic Target
Chenbo Zeng, Robert H Mach
Current Pharmaceutical Design
|
February 7, 2003
Progress in developing D3 dopamine receptor ligands as potential therapeutic agents for neurological and neuropsychiatric disorders
Robert R Luedtkea, Robert H Mach
Journal of Labelled Compounds & Radiopharmaceuticals
|
September 1, 2017
Challenges in the development of dopamine D2- and D3-selective radiotracers for PET imaging studies
Robert H Mach, Robert R Luedtke
PET Clinics
|
May 10, 2016
Challenges for Developing PET Tracers: Isotopes, Chemistry, and Regulatory Aspects
Robert H Mach, Sally W Schwarz
Organic Letters
|
October 14, 2016
Pd-Catalyzed Synthesis of Piperazine Scaffolds Under Aerobic and Solvent-Free Conditions
Sean W Reilly, Robert H Mach
Molecular Imaging and Biology
|
September 4, 2015
The PGRMC1 Protein Level Correlates with the Binding Activity of a Sigma-2 Fluorescent Probe (SW120) in Rat Brain Cells
Chenbo Zeng, Neha Garg, Robert H Mach
Page
of 29